Trulieve Cannabis (CSE: TRUL) reported their second-quarter financial results this week, boasting a record U$120.8 million in revenue, up 26% quarter to quarter, and above Refinitiv’s estimate of U$106.1 million. Adjusted EBITDA came in at U$60.5 million, and they had a free cash flow of U$39.6 million. Gross margins came in at ~77%. Trulieve announced … Continue reading Trulieve: Five Analysts Raise Price Targets Following Stellar Earnings